R. Barbaras
Research Subjects
Research Interests
R. Barbaras has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
X. Collet
4 shared publicationsB. Perret
Dpt. Lipoprotéines et Médiateurs Lipidiques, INSERM U563, Toulouse, cedex 03, France
3 shared publicationsC. Rolland
3 shared publications- François Tercé
Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France
3 shared publications B Perret
2 shared publicationsC. Malaval
2 shared publications
Latest Publications
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 153
Tu-W16:7 A new cell pathway to regulate hepatic HDL endocytosis: Involvement of ecto-F1-ATPase, purinergic receptor P2Y13 and RHO kinase
- 31 December 2006
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 7 (3) , 153
Tu-W16:7 A new cell pathway to regulate hepatic HDL endocytosis: Involvement of ecto-F1-ATPase, purinergic receptor P2Y13 and RHO kinase
- 18 October 2005
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 62 (21) , 2508-2515
The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis
Cell surface receptors for high-density lipoprotein (HDL) on hepatocytes are major partners in the regulation of cholesterol homeostasis. We recently identified a cell surface ATP synthase as a high-affinity receptor for HDL apolipoprotein A-I (apoA-I) on human hepatocytes. Stimulation of this ectopic ATP synthase by apoA-I triggered a low-affinity-receptor-dependent HDL endocytosis by a mechanism strictly related to the generation of ADP. This suggests that nucleotide G-protein- coupled receptors of the P2Y family are molecular components in this pathway. Only P2Y1 and P2Y13 are present on the membrane of hepatocytes. Using both a pharmacological approach and small interference RNA, we identified P2Y13 as the main partner in hepatic HDL endocytosis, in cultured cells as well as in situ in perfused mouse livers. We also found a new important action of the antithrombotic agent AR-C69931MX as a strong activator of P2Y13-mediated HDL endocytosis.
- 18 October 2005
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 62 (21) , 2508-2515
The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis
Cell surface receptors for high-density lipoprotein (HDL) on hepatocytes are major partners in the regulation of cholesterol homeostasis. We recently identified a cell surface ATP synthase as a high-affinity receptor for HDL apolipoprotein A-I (apoA-I) on human hepatocytes. Stimulation of this ectopic ATP synthase by apoA-I triggered a low-affinity-receptor-dependent HDL endocytosis by a mechanism strictly related to the generation of ADP. This suggests that nucleotide G-protein- coupled receptors of the P2Y family are molecular components in this pathway. Only P2Y1 and P2Y13 are present on the membrane of hepatocytes. Using both a pharmacological approach and small interference RNA, we identified P2Y13 as the main partner in hepatic HDL endocytosis, in cultured cells as well as in situ in perfused mouse livers. We also found a new important action of the antithrombotic agent AR-C69931MX as a strong activator of P2Y13-mediated HDL endocytosis.
- 1 September 2004
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 61 (18) , 2343-2360
New insight on the molecular mechanisms of high-density lipoprotein cellular interactions
High-density lipoprotein (HDL) cholesterol is an independent negative risk factor for coronary artery disease and thus represents today the only protective factor against atherosclerosis. The protective effect of HDL is mostly attributed to its central function in reverse cholesterol transport (RCT), a process whereby excess cell cholesterol is taken up and processed in HDL particles, and is later delivered to the liver for further metabolism and bile excretion. This process relies on specific interactions between HDL particles and cells, both peripheral (cholesterol efflux) and hepatic (cholesterol disposal) cells, and on the maturation of HDL particles within the vascular compartment. The plasma level of HDL cholesterol will thus result also from the complex interplay with cellular partners. Among them, some contribute to HDL formation – for instance ATP binding cassette AI protein – while others are mostly involved in HDL catabolism, the scavenger receptor-class B type I or the recently described membrane-bound ATP synthase/hydrolase. The last decade has seen major breakthroughs in the identification and elucidation of the role of cellular partners of HDL metabolism, and in their transcriptional regulations, opening up new perspectives in the modulation of HDL cholesterol.
- 1 September 2004
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 61 (18) , 2343-2360
New insight on the molecular mechanisms of high-density lipoprotein cellular interactions
High-density lipoprotein (HDL) cholesterol is an independent negative risk factor for coronary artery disease and thus represents today the only protective factor against atherosclerosis. The protective effect of HDL is mostly attributed to its central function in reverse cholesterol transport (RCT), a process whereby excess cell cholesterol is taken up and processed in HDL particles, and is later delivered to the liver for further metabolism and bile excretion. This process relies on specific interactions between HDL particles and cells, both peripheral (cholesterol efflux) and hepatic (cholesterol disposal) cells, and on the maturation of HDL particles within the vascular compartment. The plasma level of HDL cholesterol will thus result also from the complex interplay with cellular partners. Among them, some contribute to HDL formation – for instance ATP binding cassette AI protein – while others are mostly involved in HDL catabolism, the scavenger receptor-class B type I or the recently described membrane-bound ATP synthase/hydrolase. The last decade has seen major breakthroughs in the identification and elucidation of the role of cellular partners of HDL metabolism, and in their transcriptional regulations, opening up new perspectives in the modulation of HDL cholesterol.
- 1 February 2004
- Published by Elsevier in Cahiers de Nutrition et de Diététique
- Vol. 39 (1) , 78-79
Étude de l’absorption intestinale du cholestérol sur des souris surexprimant SR-BI au niveau intestinal
- 1 February 2004
- Published by Elsevier in Cahiers de Nutrition et de Diététique
- Vol. 39 (1) , 78-79
Étude de l’absorption intestinale du cholestérol sur des souris surexprimant SR-BI au niveau intestinal
- Open Access
- 1 May 1996
- Published by Elsevier in Journal of Lipid Research
- Vol. 37 (5) , 1153-1161
Identification and quantification of diacylglycerols in HDL and accessibility to lipase
- 1 May 1996
- Published by Elsevier in Journal of Lipid Research
- Vol. 37 (5) , 1153-1161
Open AccessIdentification and quantification of diacylglycerols in HDL and accessibility to lipase